COVID-19: Neuroimaging features of a pandemic
The annual societal cost of Parkinson's disease across Europe reached €22.8 billion in 2019 according to a new study within the EAN-led Cost of Illness in Neurology in Europe (COIN-Eu) initiative.
Latest Posts
-
-
Breaking newsCOVID-19ResearchCerebral venous thrombosis and SARS-CoV-2 infection: a systematic review and meta-analysis
Cerebral venous thrombosis and SARS-CoV-2 infection: a systematic review and meta-analysis -
Breaking newsCOVID-19ResearchCOVID-19 in teriflunomide-treated patients with multiple sclerosis: A case report and literature review
COVID-19 in teriflunomide-treated patients with multiple sclerosis: A case report and literature review -
Sleep apnoea is a risk factor for severe COVID-19 -
Breaking newsCOVID-19ResearchChanges of perceptions and behaviours during the phases of COVID-19 pandemic in German elderly people with neurological disorders: an observational study using telephone interviews
Changes of perceptions and behaviours during the phases of COVID-19 pandemic in German elderly people with neurological disorders: an observational study using telephone interviews -
Breaking newsCOVID-19Research
Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up
Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up -
After the outstanding success of Neuroinfection series 1 and 2 , we are now organising a very innovative new series “Inspiring people in Neurosciences” on first Saturdays of the month. -
InterviewsEAN NewsCOVID-19Top ArticlesCOVID-19 around the World: Clinician interviews on experience and impact of the virus (Japan)
COVID-19 around the World: Clinician interviews on experience and impact of the virus (Japan) -
Interview with Professor Andrea Winkler -
Paper of the MonthEAN NewsCOVID-19COVID-19 Paper of the month: Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine
For February 2020, we have selected: Polack F.P. et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine -
Clinical Fellowship Reports III 2019 -
Clinical Fellowship Reports II 2019
-
Clinical Fellowship Reports I 2019
-
Prof. C. Bassetti, President of the EAN and Prof. Pierre-Hervé Luppi, President of ESRS are pleased to announce that EAN and ESRS signed Memorandum of Understanding -
The Scientific Panel on Rare Neurological Diseases wishes to bring the below breaking news to the attention of the readership.